Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Advanced Solid Tumor × Pemetrexed × Thoracic × Clear all

Phase

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other solid neoplasm 4 Thoracic 1

Conditions

Carcinoma, Non-Small-Cell Lung 600 Lung Neoplasms 190 Mesothelioma, Malignant 46 Adenocarcinoma of Lung 41 Mesothelioma 40 Neoplasms 31 Neoplasm Metastasis 28 Carcinoma 17 Colorectal Neoplasms 15 Small Cell Lung Carcinoma 14 Parkinson Disease 4, Autosomal Dominant Lewy Body 14 NSCLC 14 Adenocarcinoma 11 Melanoma 10 Lung Diseases 10 Brain Neoplasms 10 Adenocarcinoma, Bronchiolo-Alveolar 9 Thoracic Neoplasms 8 Non-squamous Non-small Cell Lung Cancer 8 Carcinoma, Bronchogenic 8 Respiratory Tract Neoplasms 7 Non-Squamous Non-Small Cell Lung Cancer 7 Neoplasms by Site 7 Bronchial Neoplasms 7 Respiratory Tract Diseases 6 Ovarian Neoplasms 6 Neoplasms by Histologic Type 6 Meningeal Carcinomatosis 6 Squamous Cell Carcinoma of Head and Neck 5 Solitary Fibrous Tumor, Pleural 5

Interventions

pembrolizumab 1 olaparib 1 atezolizumab 1 adagrasib 1 Pemetrexed 1 Paclitaxel 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05117476 2025-11-24

MICA

Cullinan Therapeutics Inc.

Phase 1 Active not recruiting

Other solid neoplasmThoracic

Advanced Solid Tumor

Data powered by HemOnc (CC BY 4.0) Colophon ⚡